Preliminary Results from Two Clinical Studies of Selinexor to be Presented at 2022 ASH Annual Meeting

Corporate Breaking News

Home : Preliminary Results from Two Clinical Studies of Selinexor to be Presented at 2022 ASH Annual Meeting

Nov 07 2022	Preliminary Results from Two Clinical Studies of Selinexor to be Presented at 2022 ASH Annual Meeting
- Poster with updated Phase Ib TOUCH results suggest selinexor plus GemOx could provide a therapeutic option for heavily pre-treated Stage III/IV patients with relapsed/refractory (R/R) T and NK-cell lymphoma - Online abstract with results from the open-label LAUNCH study demonstrated the...


Source:https://www.prnewswire.com:443/news-releases/preliminary-results-from-two-clinical-studies-of-selinexor-to-be-presented-at-2022-ash-annual-meeting-301669857.html

Related News
» CGTN: 5ª CIIE: a porta da China abrirá ainda mais após o 20º Congresso do Partido » Home Furniture And Bedding Market In the US to grow by USD 10.86 Bn by 2026, Increasing Online Sales to Boost Market Growth - Technavio